We are live on ! Find out more
TGAN

Transphorm, Inc. Common Stock

Delisted

TGAN was delisted on the 20th of June, 2024.

0 hedge funds and large institutions have $0 invested in Transphorm, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 57 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 570 (-57)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

100% less capital invested

Capital invested by funds: $203M → $0 (-$203M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 57

Holders
Holders Change
-57
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
57
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AIP
51
Ameritas Investment Partners
Nebraska
-$7.89K -1,608 Closed
AB
52
Amalgamated Bank
New York
-$4K -744 Closed
Carson Wealth (CWM LLC)
53
Carson Wealth (CWM LLC)
Nebraska
-$3K -649 Closed
Russell Investments Group
54
Russell Investments Group
United Kingdom
-$1.32K -269 Closed
NA
55
NewEdge Advisors
Louisiana
-$491 -100 Closed
Nisa Investment Advisors
56
Nisa Investment Advisors
Missouri
-$275 -56 Closed
AWM
57
Avior Wealth Management
Nebraska
-$14 -3 Closed

TGAN Hedge Fund Activity: Q2 2024 in Review

0 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Transphorm, Inc. Common Stock (TGAN) for Q2 2024, worth a combined $0 — down 100% from $203M a quarter earlier.

Sellers outnumbered buyers: 57 funds closed out of TGAN and 0 opened new positions — a net loss of 57 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Kohlberg Kravis Roberts & Co, exiting entirely with an estimated $120M sold.

  • 0 institutional investors held Transphorm, Inc. Common Stock (TGAN) as of Q2 2024, down from 57 in Q1 2024.
  • Funds reported $0 of Transphorm, Inc. Common Stock stock for Q2 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Transphorm, Inc. Common Stock positions in Q2 2024 and 57 closed out, a net change of -57 holders.
  • The largest Transphorm, Inc. Common Stock seller in Q2 2024 was Kohlberg Kravis Roberts & Co, an estimated $120M sold.

Based on aggregated 13F filings for Q2 2024.